Investor Presentaiton slide image

Investor Presentaiton

Legend: Start here - stay here Be the preferred partner across the entire peptide value chain Drug discovery & lead optimization API development & manufacturing: From early phases to commercialization Clinical development Pre-clinical research Phase I Phase II Phase III NDA filing GMP clinical batches Drug product launch Commercialisation Generization API manufacturing Non-GMP batches Scale-up batches Commercial supply PPQ batches API process & analytical development Process development Analytical method development Process validation Analytical method validation Product release & LCM Developmental stability studies and ICH stability Annual product review Regulatory support & documentation CMC documentation and filing support API - Active pharmaceutical ingredient; CMC - Chemistry, manufacturing & controls; GMP - Good manufacturing practice; ICH - International council for harmonization; LCM - Life cycle management; NDA - New drug application; PPQ - Process performance qualification GLOBAL SUPPORT FOR A QUALITY SOLUTION 13 Post approval changes PolyPeptide GROUP
View entire presentation